Morenike Ayodele

University of Birmingham - Institute of Immunology and Immunotherapy

Birmingham

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS

315

SSRN CITATIONS

0

CROSSREF CITATIONS

1

Scholarly Papers (3)

1.

Profile of Humoral and Cellular Immune Responses to Single BNT162b2 or ChAdOx1 Vaccine in Residents and Staff Within Residential Care Homes (VIVALDI Study)

Number of pages: 17 Posted: 04 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - UCL Institute of Health Informatics, University College London - Institute for Health Informatics, University College London - UCL Institute of Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 163 (256,380)
Citation 2

Abstract:

Loading...

2.

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities

Number of pages: 29 Posted: 09 Dec 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 139 (291,456)

Abstract:

Loading...

Long Term Care Facility, Resident, COVID-19, SARS-CoV-2, Vaccination

3.

Vaccine Subtype and Dose Interval Determine Immunogenicity of Primary Series COVID-19 Vaccines in Older People

Number of pages: 29 Posted: 27 Apr 2022
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 13 (776,987)

Abstract:

Loading...

COVID-19, vaccines, elderly, primary series, BNT162b2, ChAdOx1